Catechol-O-methyltransferase (COMT) is involved in the metabolism of n
eurotransmitters such as epinephrine, norepinephrine and dopamine. For
melanocytes, the enzyme is of particular importance in preventing the
formation of toxic o-quinones during melanin synthesis. It has been s
uggested that COMT plays a regulatory role in melanin synthesis. Indee
d, when the melanin precursor molecule DHI(2C) is methylated by COMT i
t is no longer available for incorporation into melanin. Auto-destruct
ion by intermediates of melanin metabolism has been implicated in the
aetiology of vitiligo. Therefore enzyme activities in vitiligo patient
s and in healthy controls mere compared. Systemic COMT activities were
measured using red blood cells (RBC) as starting material. However, a
s local alterations in COMT activity may be specifically involved in v
itiligo, the enzyme activity was also measured in epidermal homogenate
s. Finally, to ascribe epidermal COMT activity to the responsible cell
type(s), enzyme activity was measured in cultured vitiligo non-lesion
al melanocytes and melanocytes from healthy controls as well as in cul
tured keratinocytes from lesional skin and in purified keratinocytes f
rom control skin. It was found that epidermal homogenates from vitilig
o patients expressed higher levels of COMT activity than homogenates f
rom healthy controls. Such differences were not found at the systemic
level (i.e. in RBC) nor could they be explained by measurements on sep
arately cultured epidermal cell types, indicating that the COMT activi
ty was induced at the tissue level by extracellular factors. It is pos
sible that elevated levels of catecholamines secreted by keratinocytes
or by nerve endings in vitiliginous skin in close proximity to the ep
idermis cause damage to all epidermal cells, an effect which is insuff
iciently neutralized by elevated levels of COMT activity. Catecholamin
es may well be more damaging to the melanocytes than to the keratinocy
tes because of their slower turnover rate.